<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39328154</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1778-3585</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>European psychiatry : the journal of the Association of European Psychiatrists</Title><ISOAbbreviation>Eur Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review.</ArticleTitle><Pagination><StartPage>e60</StartPage><MedlinePgn>e60</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e60</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1192/j.eurpsy.2024.1770</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cognitive impairment (CI) is one of the most prevalent and burdensome consequences of COVID-19 infection, which can persist up to months or even years after remission of the infection. Current guidelines on post-COVID CI are based on available knowledge on treatments used for improving CI in other conditions. The current review aims to provide an updated overview of the existing evidence on the efficacy of treatments for post-COVID CI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search was conducted for studies published up to December 2023 using three databases (PubMed-Scopus-ProQuest). Controlled and noncontrolled trials, cohort studies, case series, and reports testing interventions on subjects with CI following COVID-19 infection were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After screening 7790 articles, 29 studies were included. Multidisciplinary approaches, particularly those combining cognitive remediation interventions, physical exercise, and dietary and sleep support, may improve CI and address the different needs of individuals with post-COVID-19 condition. Cognitive remediation interventions can provide a safe, cost-effective option and may be tailored to deficits in specific cognitive domains. Noninvasive brain stimulation techniques and hyperbaric oxygen therapy showed mixed and preliminary results. Evidence for other interventions, including pharmacological ones, remains sparse. Challenges in interpreting existing evidence include heterogeneity in study designs, assessment tools, and recruitment criteria; lack of long-term follow-up; and under-characterization of samples in relation to confounding factors.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Further research, grounded on shared definitions of the post-COVID condition and on the accurate assessment of COVID-related CI, in well-defined study samples and with longer follow-ups, is crucial to address this significant unmet need.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Melillo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1477-7916</Identifier><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrottelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7771-1845</Identifier><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caporusso</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4980-0466</Identifier><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coltorti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Giulia Maria</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giuliani</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pezzella</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8442-5385</Identifier><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bucci</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mucci</LastName><ForeName>Armida</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6195-9456</Identifier><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galderisi</LastName><ForeName>Silvana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1592-7656</Identifier><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maj</LastName><ForeName>Mario</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8408-0711</Identifier><AffiliationInfo><Affiliation>World Health Organization (WHO) Collaborating Center, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Psychiatry</MedlineTA><NlmUniqueID>9111820</NlmUniqueID><ISSNLinking>0924-9338</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList><CoiStatement>Giulia Maria Giordano reports consulting fees from Angelini. Armida Mucci reports consulting fees from Pierre Fabre, Rovi, and Boehringer Ingelheim; patents with Pierre Fabre; and participation on data safety monitoring boards with Angelini and Boehringer Ingelheim. Silvana Galderisi reports consulting fees from Gedeon Richter; honoraria from Angelini, Boehringer Ingelheim, Gedeon Richter, Janssen, Lundbeck, Otsuka, Recordati, and Rovi; and participation on data safety monitoring boards with Angelini, Boehringer Ingelheim, Janssen, and Rovi. No other competing interests were declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>5</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39328154</ArticleId><ArticleId IdType="pmc">PMC11457117</ArticleId><ArticleId IdType="doi">10.1192/j.eurpsy.2024.1770</ArticleId><ArticleId IdType="pii">S092493382401770X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO). WHO coronavirus (COVID-19)dashboard, https://data.who.int/dashboards/covid19/cases?n=c;
2024.  [accessed 9 January 2024].</Citation></Reference><Reference><Citation>Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front Public Health. 2021;8:582932. doi:10.3389/fpubh.2020.582932.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.582932</ArticleId><ArticleId IdType="pmc">PMC7844320</ArticleId><ArticleId IdType="pubmed">33520910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Have M, Tuithof M, van Dorsselaer S, Schouten F, Luik AI, de Graaf R. Prevalence and trends of common mental disorders from 2007-2009 to 2019-2022: Results from the Netherlands mental health survey and incidence studies (NEMESIS), including comparison of prevalence rates before vs. during the COVID-19 pandemic. World Psychiatry. 2023;22(2):275&#x2013;85. doi:10.1002/wps.21087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.21087</ArticleId><ArticleId IdType="pmc">PMC10168151</ArticleId><ArticleId IdType="pubmed">37159351</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Pe&#xf1;as C, Notarte KI, Macasaet R, Velasco JV, Catahay JA, Ver AT, et al. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: a systematic review and meta-analysis. J Infect. 2024;88(2):77&#x2013;88. doi:10.1016/j.jinf.2023.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.12.004</ArticleId><ArticleId IdType="pubmed">38101521</ArticleId></ArticleIdList></Reference><Reference><Citation>Galderisi S, Perrottelli A, Giuliani L, Pisaturo MA, Monteleone P, Pagliano P, et al. Cognitive impairment after recovery from COVID-19: frequency, profile, and relationships with clinical and laboratory indices. Eur Neuropsychopharmacol. 2024;79:22&#x2013;31. doi:10.1016/j.euroneuro.2023.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2023.11.001</ArticleId><ArticleId IdType="pubmed">38065006</ArticleId></ArticleIdList></Reference><Reference><Citation>Latifi A, Flegr J. Is recovery just the beginning? Persistent symptoms and health and performance deterioration in post-COVID-19, non-hospitalized university students-a cross-sectional study. Biol Methods Protoc. 2023;8(1):bpad037. doi:10.1093/biomethods/bpad037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomethods/bpad037</ArticleId><ArticleId IdType="pmc">PMC10739555</ArticleId><ArticleId IdType="pubmed">38144461</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyedalinaghi S, Bagheri A, Razi A, Mojdeganlou P, Mojdeganlou H, Afsahi AM, et al. Late complications of COVID-19; an umbrella review on current systematic reviews. Arch Acad Emerg Med. 2023;11(1):e28. doi:10.22037/aaem.v11i1.1907.</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/aaem.v11i1.1907</ArticleId><ArticleId IdType="pmc">PMC10197916</ArticleId><ArticleId IdType="pubmed">37215236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Long-Term consequences of COVID-19 at 6 months and above: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:6865. doi:10.3390/ijerph19116865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19116865</ArticleId><ArticleId IdType="pmc">PMC9180091</ArticleId><ArticleId IdType="pubmed">35682448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Long-term consequences of asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis. Intern J Environ Res Public Health. 2023;20:1613. doi:10.3390/ijerph20021613.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021613</ArticleId><ArticleId IdType="pmc">PMC9863678</ArticleId><ArticleId IdType="pubmed">36674367</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e7. doi:10.1016/s1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman B, Casiraghi E, Blau H, Chan L, Haendel MA, Laraway B, et al. Risk of new-onset psychiatric sequelae of COVID-19 in the early and late post-acute phase. World Psychiatry. 2022;21(2):319&#x2013;20. 10.1002/wps.20992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20992</ArticleId><ArticleId IdType="pmc">PMC9077621</ArticleId><ArticleId IdType="pubmed">35524622</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart DE, Wasserman D, Appelbaum PS. COVID-19 and psychiatrists&#x2019; responsibilities: an update of the WPA position paper. World Psychiatry. 2023;22(2):342&#x2013;3. doi:10.1002/wps.21103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.21103</ArticleId><ArticleId IdType="pmc">PMC10168153</ArticleId><ArticleId IdType="pubmed">37159377</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrottelli A, Sansone N, Giordano GM, Caporusso E, Giuliani L, Melillo A, et al. Cognitive impairment after post-acute COVID-19 infection: a systematic review of the literature. J Pers Med. 2022;12(12):2070. doi:10.3390/jpm12122070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12122070</ArticleId><ArticleId IdType="pmc">PMC9781311</ArticleId><ArticleId IdType="pubmed">36556290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135. doi:10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, Palmer K, Calandri I, Guekht A, Beghi E, Carroll W, et al. Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. 2022;18(5):1047&#x2013;66. doi:10.1002/alz.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, et al. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells. 2023;12:816. doi:10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Grimshaw M, Chirino-P&#xe9;rez A, Flores-Silva FD, Vald&#xe9;s-Ferrer SI, Vargas-Mart&#xed;nez M, Jim&#xe9;nez-&#xc1;vila AI, et al. Critical role of acute hypoxemia on the cognitive impairment after severe COVID-19 pneumonia: a multivariate causality model analysis. Neurol Sci. 2022;43(4):2217&#x2013;29. doi:10.1007/s10072-021-05798-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05798-8</ArticleId><ArticleId IdType="pmc">PMC8754526</ArticleId><ArticleId IdType="pubmed">35022935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves NG, Aliberti MJR, Bertola L, Avelino-Silva T, Dias MB, Apolinario D, et al. Dissipating the fog: cognitive trajectories and risk factors 1 year after COVID-19 hospitalization. Alzheimers Dement. 2023;19(9):3771&#x2013;82. doi:10.1002/alz.12993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12993</ArticleId><ArticleId IdType="pubmed">36861807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529. doi:10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79(5):509&#x2013;17. doi:10.1001/jamaneurol.2022.0461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#xa0;284&#xa0;437 patients. Lancet Psychiatry. 2022;9(10):815&#x2013;27. doi:10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan M, Wang X, Gong M, Wang Q, Li Y, Jia J. Post-COVID cognitive dysfunction: current status and research recommendations for high risk population. Lancet Reg Health West Pac. 2023;38:100836. doi:10.1016/j.lanwpc.2023.100836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2023.100836</ArticleId><ArticleId IdType="pmc">PMC10344681</ArticleId><ArticleId IdType="pubmed">37457901</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). Clinical management of COVID-19: living guideline. 6th ed. Geneva: World Health Organization; 2023.</Citation></Reference><Reference><Citation>Cicerone KD, Goldin Y, Ganci K, Rosenbaum A, Wethe JV, Langenbahn DM, et al. Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014. Arch Phys Med Rehabil. 2019;100(8):1515&#x2013;33. doi:10.1016/j.apmr.2019.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2019.02.011</ArticleId><ArticleId IdType="pubmed">30926291</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;ller M, Borg K, Janson C, Lerm M, Normark J, Niward K. Cognitive dysfunction in post-COVID-19 condition: mechanisms, management, and rehabilitation. J Intern Med. 2023;294(5):563&#x2013;81. doi:10.1111/joim.13720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13720</ArticleId><ArticleId IdType="pubmed">37766515</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu QM, Fitzpatrick AL, Cope JR, Bertolli J, Sotoodehnia N, West TE, et al. Estimates of incidence and predictors of fatiguing illness after SARS-CoV-2 infection. Emerg Infect Dis. 2024;30(3):539&#x2013;47. doi:10.3201/eid3003.231194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid3003.231194</ArticleId><ArticleId IdType="pmc">PMC10902536</ArticleId><ArticleId IdType="pubmed">38407166</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnhoff S, Koehler L, Haghikia A, Zaehle T. The therapeutic potential of non-invasive brain stimulation for the treatment of long-COVID-related cognitive fatigue. Front Immunol. 2022;13:935614. doi:10.3389/fimmu.2022.935614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.935614</ArticleId><ArticleId IdType="pmc">PMC9869163</ArticleId><ArticleId IdType="pubmed">36700201</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugazzaro S, Contri A, Esseroukh O, Kaleci S, Croci S, Massari M, et al. Rehabilitation interventions for post-acute COVID-19 syndrome: a systematic review. Int J Environ Res Public Health. 2022;19(9):5185. doi:10.3390/ijerph19095185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095185</ArticleId><ArticleId IdType="pmc">PMC9104923</ArticleId><ArticleId IdType="pubmed">35564579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandan JS, Brown KR, Simms-Williams N, Bashir NZ, Camaradou J, Heining D, et al. Non-pharmacological therapies for post-viral syndromes, including long COVID: A systematic review. Int J Environ Res Public Health. 2023;20(4): doi:10.3390/ijerph20043477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20043477</ArticleId><ArticleId IdType="pmc">PMC9967466</ArticleId><ArticleId IdType="pubmed">36834176</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawke LD, Nguyen ATP, Ski CF, Thompson DR, Ma C, Castle D. Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic review of registered trials. Psychol Med. 2022;52(13):2426&#x2013;40. 10.1017/s0033291722002203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0033291722002203</ArticleId><ArticleId IdType="pmc">PMC9300978</ArticleId><ArticleId IdType="pubmed">35768406</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawzy NA, Abou Shaar B, Taha RM, Arabi TZ, Sabbah BN, Alkodaymi MS, et al. A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19 syndrome and registered on WHO international clinical trials platform. Clin Microbiol Infect. 2023;29(5):570&#x2013;7. doi:10.1016/j.cmi.2023.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2023.01.007</ArticleId><ArticleId IdType="pmc">PMC9837206</ArticleId><ArticleId IdType="pubmed">36642173</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Guekht A, Allegri RF, Ashraf M, Baykan B, Crivelli L, et al. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: a consensus statement and scoping review from the global COVID-19 neuro research coalition. J Neurol Sci. 2023;454:120827. doi:10.1016/j.jns.2023.120827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2023.120827</ArticleId><ArticleId IdType="pubmed">37856998</ArticleId></ArticleIdList></Reference><Reference><Citation>Fesharaki-Zadeh A, Lowe N, Arnsten AF. Clinical experience with the &#x3b1;2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in &#x201c;long-COVID19&#x201d;. Neuroimmunol Rep. 2023;3:100154.</Citation></Reference><Reference><Citation>De Luca P, Camaioni A, Marra P, Salzano G, Carriere G, Ricciardi L, et al. Effect of ultra-micronized Palmitoylethanolamide and Luteolin on olfaction and memory in patients with long COVID: results of a longitudinal study. Cells. 2022;11(16):2552. doi:10.3390/cells11162552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11162552</ArticleId><ArticleId IdType="pmc">PMC9406356</ArticleId><ArticleId IdType="pubmed">36010630</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>JBI. JBI critical appraisal tools, https://jbi.global/critical-appraisal-tools;
2024.  [accessed 9 January 2024].</Citation></Reference><Reference><Citation>Zilberman-Itskovich S, Catalogna M, Sasson E, Elman-Shina K, Hadanny A, Lang E, et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep. 2022;12(1):11252. doi:10.1038/s41598-022-15565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen R, Arany PR. Use of either transcranial or whole-body photobiomodulation treatments improves COVID-19 brain fog. J Biophotonics. 2023;16(8):e202200391. doi:10.1002/jbio.202200391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbio.202200391</ArticleId><ArticleId IdType="pubmed">37018063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausswirth C, Schmit C, Rougier Y, Coste A. Positive impacts of a four-week neuro-meditation program on cognitive function in post-acute sequelae of COVID-19 patients: a randomized controlled trial. Int J Environ Res Public Health. 2023;20(2):1361. doi:10.3390/ijerph20021361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021361</ArticleId><ArticleId IdType="pmc">PMC9858974</ArticleId><ArticleId IdType="pubmed">36674117</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace V, Ortelli P, Dezi S, Ferrazzoli D, Alibardi A, Bonini I, et al. Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABA(B)-ergic activity and cortical plasticity in long COVID-19 syndrome. Clin Neurophysiol. 2023;145:81&#x2013;8. doi:10.1016/j.clinph.2022.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2022.10.017</ArticleId><ArticleId IdType="pmc">PMC9650483</ArticleId><ArticleId IdType="pubmed">36455453</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver-Mas S, Delgado-Alonso C, Delgado-&#xc1;lvarez A, D&#xed;ez-Cirarda M, Cuevas C, Fern&#xe1;ndez-Romero L, et al. Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study. Brain Commun. 2023;5(2):fcad117. doi:10.1093/braincomms/fcad117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad117</ArticleId><ArticleId IdType="pmc">PMC10116605</ArticleId><ArticleId IdType="pubmed">37091591</ArticleId></ArticleIdList></Reference><Reference><Citation>Momtazmanesh S, Ansari S, Izadi Z, Shobeiri P, Vatankhah V, Seifi A, et al. Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: a randomized, double-blind, and placebo-controlled study. J Psychosom Res. 2023;172:111389. doi:10.1016/j.jpsychores.2023.111389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2023.111389</ArticleId><ArticleId IdType="pmc">PMC10229204</ArticleId><ArticleId IdType="pubmed">37327698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pooladgar P, Sakhabakhsh M, Soleiman-Meigooni S, Taghva A, Nasiri M, Darazam IA. The effect of donepezil hydrochloride on post-COVID memory impairment: a randomized controlled trial. J Clin Neurosci. 2023;118:168&#x2013;74. doi:10.1016/j.jocn.2023.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2023.09.005</ArticleId><ArticleId IdType="pubmed">37952347</ArticleId></ArticleIdList></Reference><Reference><Citation>Samper-Pardo M, Le&#xf3;n-Herrera S, Oliv&#xe1;n-Bl&#xe1;zquez B, M&#xe9;ndez-L&#xf3;pez F, Dom&#xed;nguez-Garc&#xed;a M, S&#xe1;nchez-Recio R. Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a randomized, 3-month follow-up clinical trial. Sci Rep. 2023;13(1):7943. doi:10.1038/s41598-023-35058-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-35058-y</ArticleId><ArticleId IdType="pmc">PMC10187508</ArticleId><ArticleId IdType="pubmed">37193738</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanashyan M, Morozova S, Raskurazhev A, Kuznetsova P. A prospective randomized, double-blind placebo-controlled study to evaluate the effectiveness of neuroprotective therapy using functional brain MRI in patients with post-covid chronic fatigue syndrome. Biomed Pharmacother. 2023;168:115723. doi:10.1016/j.biopha.2023.115723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.115723</ArticleId><ArticleId IdType="pubmed">37862966</ArticleId></ArticleIdList></Reference><Reference><Citation>Palladini M, Bravi B, Colombo F, Caselani E, Di Pasquasio C, D&#x2019;Orsi G, et al. Cognitive remediation therapy for post-acute persistent cognitive deficits in COVID-19 survivors: a proof-of-concept study. Neuropsychol Rehabil. 2023;33(7):1207&#x2013;24. doi:10.1080/09602011.2022.2075016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09602011.2022.2075016</ArticleId><ArticleId IdType="pubmed">35583357</ArticleId></ArticleIdList></Reference><Reference><Citation>Asimakos A, Spetsioti S, Mavronasou A, Gounopoulos P, Siousioura D, Dima E, et al. Additive benefit of rehabilitation on physical status, symptoms and mental health after hospitalisation for severe COVID-19 pneumonia. BMJ Open Respir Res. 2023;10(1):e001377. doi:10.1136/bmjresp-2022-001377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2022-001377</ArticleId><ArticleId IdType="pmc">PMC10314701</ArticleId><ArticleId IdType="pubmed">37385736</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki N, Yamatoku M, Tsuchida T, Sato H, Yamaguchi K. Effect of repetitive transcranial magnetic stimulation on long coronavirus disease 2019 with fatigue and cognitive dysfunction. Prog Rehabil Med. 2023;8:20230004. doi:10.2490/prm.20230004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2490/prm.20230004</ArticleId><ArticleId IdType="pmc">PMC9968785</ArticleId><ArticleId IdType="pubmed">36861061</ArticleId></ArticleIdList></Reference><Reference><Citation>Du&#xf1;abeitia JA, Mera F, Baro &#xd3;, Jadad-Garcia T, Jadad AR. Personalized computerized training for cognitive dysfunction after COVID-19: a before-and-after feasibility pilot study. Int J Environ Res Public Health. 2023;20(4):3100. doi:10.3390/ijerph20043100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20043100</ArticleId><ArticleId IdType="pmc">PMC9966004</ArticleId><ArticleId IdType="pubmed">36833793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove M, Fogacci F, Quattrocchi S, Veronesi M, Cicero AFG. Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection. Arch Med Sci. 2021;17(6):1797&#x2013;9. doi:10.5114/aoms/141502.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms/141502</ArticleId><ArticleId IdType="pmc">PMC8641516</ArticleId><ArticleId IdType="pubmed">34900061</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes E, Gerlis C, Chaplin E, Gardiner N, Singh SJ. Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition - a cohort study. Chron Respir Dis. 2021;18:14799731211015691. doi:10.1177/14799731211015691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211015691</ArticleId><ArticleId IdType="pmc">PMC8114752</ArticleId><ArticleId IdType="pubmed">33957805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupferschmitt A, J&#xf6;bges M, Randerath J, Hinterberger T, Loew TH, K&#xf6;llner V. Attention deficits and depressive symptoms improve differentially after rehabilitation of post-COVID condition &#x2013; a prospective cohort study. J Psychosom Res. 2023;175:111540. doi:10.1016/j.jpsychores.2023.111540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2023.111540</ArticleId><ArticleId IdType="pubmed">37918327</ArticleId></ArticleIdList></Reference><Reference><Citation>Albu S, Rivas Zozaya N, Murillo N, Garc&#xed;a-Molina A, Figueroa Chac&#xf3;n CA, Kumru H. Multidisciplinary outpatient rehabilitation of physical and neurological sequelae and persistent symptoms of covid-19: a prospective, observational cohort study. Disabil Rehabil. 2022;44(22):6833&#x2013;40. doi:10.1080/09638288.2021.1977398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2021.1977398</ArticleId><ArticleId IdType="pubmed">34559592</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini A, Vaezmousavi M, Shirvani H. The effectiveness of cognitive-motor training on reconstructing cognitive health components in older male adults, recovered from the COVID-19. Neurol Sci. 2022;43(2):1395&#x2013;403. doi:10.1007/s10072-021-05502-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05502-w</ArticleId><ArticleId IdType="pmc">PMC8322109</ArticleId><ArticleId IdType="pubmed">34328579</ArticleId></ArticleIdList></Reference><Reference><Citation>Everaerts S, Heyns A, Langer D, Beyens H, Hermans G, Troosters T, et al. COVID-19 recovery: benefits of multidisciplinary respiratory rehabilitation. BMJ Open Respir Res. 2021;8(1):e000837. doi:10.1136/bmjresp-2020-000837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2020-000837</ArticleId><ArticleId IdType="pmc">PMC8423511</ArticleId><ArticleId IdType="pubmed">34489236</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaiotti P, Cirac&#xec; C, Donelli D, Oggioni C, Rizzi B, Savi F, et al. Effects of multidisciplinary rehabilitation enhanced with neuropsychological treatment on post-acute SARS-CoV-2 cognitive impairment (brain fog): an observational study. Brain Sci. 2023;13(5):791. doi:10.3390/brainsci13050791.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13050791</ArticleId><ArticleId IdType="pmc">PMC10216015</ArticleId><ArticleId IdType="pubmed">37239263</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x141;ucko&#x15b; M, Cieleb&#x105;k K, Kami&#x144;ski P. EEG neurofeedback in the treatment of cognitive dysfunctions after the infection of SARS-COV-2 and long COVID-19. Acta Neuropsychol. 2021;19(3):361&#x2013;72. doi:10.5604/01.3001.0015.2464.</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/01.3001.0015.2464</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaiyat AM, Sasson E, Wang Z, Khairy S, Ginzarly M, Qureshi U, et al. Hyperbaric oxygen treatment for long coronavirus disease-19: a&#xa0;case report. J Med Case Rep. 2022;16(1):80. doi:10.1186/s13256-022-03287-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-022-03287-w</ArticleId><ArticleId IdType="pmc">PMC8848789</ArticleId><ArticleId IdType="pubmed">35168680</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel BA, Zhou W, Huber F, Schmidt F, Sabel K, Gonschorek A, et al. Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment. Restor Neurol Neurosci. 2021;39(6):393&#x2013;408. doi:10.3233/rnn-211249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/rnn-211249</ArticleId><ArticleId IdType="pmc">PMC8764598</ArticleId><ArticleId IdType="pubmed">34924406</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick E, Spengler RN, Ignatowski TA, Wassel M, Laborde S. Rapid improvement in severe long COVID following perispinal etanercept. Curr Med Res Opin. 2022;38(12):2013&#x2013;20. doi:10.1080/03007995.2022.2096351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2096351</ArticleId><ArticleId IdType="pubmed">35791687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CH, Chen SJ, Chen YC, Tsai HC. A 30-year-old woman with an 8-week history of anxiety, depression, insomnia, and mild cognitive impairment following COVID-19 who responded to accelerated bilateral theta-burst transcranial magnetic stimulation over the prefrontal cortex. Am J Case Rep. 2023;24:e938732. doi:10.12659/ajcr.938732.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/ajcr.938732</ArticleId><ArticleId IdType="pmc">PMC10077184</ArticleId><ArticleId IdType="pubmed">37004143</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavendish BA, Lima A, Bertola L, Charvet L, Bikson M, Brunoni AR, et al. Combination of transcranial direct current stimulation with online cognitive training improves symptoms of post-acute sequelae of COVID-19: a case series. Brain Stimul. 2022;15(6):1375&#x2013;7. doi:10.1016/j.brs.2022.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2022.09.008</ArticleId><ArticleId IdType="pmc">PMC9528061</ArticleId><ArticleId IdType="pubmed">36202328</ArticleId></ArticleIdList></Reference><Reference><Citation>Zifko UA, Yacob M, Braun BJ, Dietz GPH. Alleviation of post-COVID-19 cognitive deficits by treatment with EGb 761&#xae;: a case series. Am J Case Rep. 2022;23:e937094. doi:10.12659/ajcr.937094.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/ajcr.937094</ArticleId><ArticleId IdType="pmc">PMC9523733</ArticleId><ArticleId IdType="pubmed">36156538</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda Y, Sato A, Fujii K, Nagano Y, Iwasa M, Hirahata K, et al. A pilot study of the effect of transcranial magnetic stimulation treatment on cognitive dysfunction associated with post COVID-19 condition. Psychiatry Clin Neurosci. 2023;77(4):241&#x2013;2. doi:10.1111/pcn.13527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13527</ArticleId><ArticleId IdType="pubmed">36594421</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T, Gonevski M, Clark C, Baitule S, Sharma K, Magar A, et al. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin Med (Lond). 2021;21(6):e629&#x2013;e32. doi:10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowie CR, Bell MD, Fiszdon JM, Johannesen JK, Lindenmayer JP, McGurk SR, et al. Cognitive remediation for schizophrenia: an expert working group white paper on core techniques. Schizophr Res. 2020;215:49&#x2013;53. doi:10.1016/j.schres.2019.10.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2019.10.047</ArticleId><ArticleId IdType="pubmed">31699627</ArticleId></ArticleIdList></Reference><Reference><Citation>Elyamany O, Leicht G, Herrmann CS, Mulert C. Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatry. Eur Arch Psychiatry Clin Neurosci. 2021;271(1):135&#x2013;56. doi:10.1007/s00406-020-01209-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-020-01209-9</ArticleId><ArticleId IdType="pmc">PMC7867505</ArticleId><ArticleId IdType="pubmed">33211157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanches C, Stengel C, Godard J, Mertz J, Teichmann M, Migliaccio R, et al. Past, present, and future of non-invasive brain stimulation approaches to treat cognitive impairment in neurodegenerative diseases: time for a comprehensive critical review. Front Aging Neurosci. 2020;12:578339. doi:10.3389/fnagi.2020.578339.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.578339</ArticleId><ArticleId IdType="pmc">PMC7854576</ArticleId><ArticleId IdType="pubmed">33551785</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegert A, Diedrich L, Antal A. New methods, old brains-a systematic review on the effects of tDCS on the cognition of elderly people. Front Hum Neurosci. 2021;15:730134. doi:10.3389/fnhum.2021.730134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2021.730134</ArticleId><ArticleId IdType="pmc">PMC8578968</ArticleId><ArticleId IdType="pubmed">34776903</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth SJ, Taylor JR, Brown LJE, Pobric G. The effects of transcranial alternating current stimulation on memory performance in healthy adults: a systematic review. Cortex. 2022;147:112&#x2013;39. doi:10.1016/j.cortex.2021.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2021.12.001</ArticleId><ArticleId IdType="pubmed">35032750</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover S, Fayzullina R, Bullard BM, Levina V, Reinhart RMG. A meta-analysis suggests that tACS improves cognition in healthy, aging, and psychiatric populations. Sci Transl Med. 2023;15(697):eabo2044. doi:10.1126/scitranslmed.abo2044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo2044</ArticleId><ArticleId IdType="pmc">PMC10860714</ArticleId><ArticleId IdType="pubmed">37224229</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissim NR, McAfee DC, Edwards S, Prato A, Lin JX, Lu Z, et al. Efficacy of transcranial alternating current stimulation in the enhancement of working memory performance in healthy adults: a systematic meta-analysis. Neuromodulation. 2023;26(4):728&#x2013;37. doi:10.1016/j.neurom.2022.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurom.2022.12.014</ArticleId><ArticleId IdType="pmc">PMC10257732</ArticleId><ArticleId IdType="pubmed">36759231</ArticleId></ArticleIdList></Reference><Reference><Citation>Begemann MJ, Brand BA, &#x106;ur&#x10d;i&#x107;-Blake B, Aleman A, Sommer IE. Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis. Psychol Med. 2020;50(15):2465&#x2013;86. doi:10.1017/s0033291720003670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0033291720003670</ArticleId><ArticleId IdType="pmc">PMC7737055</ArticleId><ArticleId IdType="pubmed">33070785</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Li CL, Qu Y, Yang YX, Zhao J. Effects and neuroprotective mechanisms of vagus nerve stimulation on cognitive impairment with traumatic brain injury in animal studies: a systematic review and meta-analysis. Front Neurol. 2022;13:963334. doi:10.3389/fneur.2022.963334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.963334</ArticleId><ArticleId IdType="pmc">PMC9551312</ArticleId><ArticleId IdType="pubmed">36237612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhang J, Guo C, He J, Zhang S, Wang Y, et al. The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: a double blinded randomized clinical trial. Brain Stimul. 2022;15(6):1405&#x2013;14. doi:10.1016/j.brs.2022.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2022.09.003</ArticleId><ArticleId IdType="pubmed">36150665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridgewell C, Heaton KJ, Hildebrandt A, Couse J, Leeder T, Neumeier WH. The effects of transcutaneous auricular vagal nerve stimulation on cognition in healthy individuals: a meta-analysis. Neuropsychology. 2021;35(4):352&#x2013;65. doi:10.1037/neu0000735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/neu0000735</ArticleId><ArticleId IdType="pubmed">34043386</ArticleId></ArticleIdList></Reference><Reference><Citation>Naparstek S, Yeh AK, Mills-Finnerty C. Transcutaneous Vagus nerve stimulation (tVNS) applications in cognitive aging: a review and commentary. Front Aging Neurosci. 2023;15:1145207. doi:10.3389/fnagi.2023.1145207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2023.1145207</ArticleId><ArticleId IdType="pmc">PMC10366452</ArticleId><ArticleId IdType="pubmed">37496757</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifilio E, Shortell D, Olshan S, O&#x2019;Neal A, Coyne J, Lamb D, et al. Impact of transcutaneous vagus nerve stimulation on healthy cognitive and brain aging. Front Neurosci. 2023;17:1184051. doi:10.3389/fnins.2023.1184051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1184051</ArticleId><ArticleId IdType="pmc">PMC10416636</ArticleId><ArticleId IdType="pubmed">37575296</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Peluso MJ, Rodgers K, Aberg JA, Patterson TF, Tamburro R, et al. Therapeutic trials for long COVID-19: a call to action from the interventions taskforce of the RECOVER initiative. Front Immunol. 2023;14:1129459. doi:10.3389/fimmu.2023.1129459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1129459</ArticleId><ArticleId IdType="pmc">PMC10034329</ArticleId><ArticleId IdType="pubmed">36969241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Kandiah N, Hsu JL, Suthisisang C, Udommongkol C, Dash A. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer&#x2019;s disease. Br J Pharmacol. 2017;174(23):4224&#x2013;32. doi:10.1111/bph.14030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14030</ArticleId><ArticleId IdType="pmc">PMC5715569</ArticleId><ArticleId IdType="pubmed">28901528</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Zhu Y, Fu P, Yang J. A network pharmacology based research on the mechanism of donepezil in treating Alzheimer&#x2019;s disease. Front Aging Neurosci. 2022;14:822480. doi:10.3389/fnagi.2022.822480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.822480</ArticleId><ArticleId IdType="pmc">PMC9031729</ArticleId><ArticleId IdType="pubmed">35462691</ArticleId></ArticleIdList></Reference><Reference><Citation>Assogna M, Di Lorenzo F, Martorana A, Koch G. Synaptic effects of Palmitoylethanolamide in neurodegenerative disorders. Biomol Ther. 2022;12(8):1161. doi:10.3390/biom12081161.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12081161</ArticleId><ArticleId IdType="pmc">PMC9405819</ArticleId><ArticleId IdType="pubmed">36009055</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordaro M, Cuzzocrea S, Crupi R. An update of Palmitoylethanolamide and Luteolin effects in preclinical and clinical studies of Neuroinflammatory events. Antioxidants. 2020;9(3):216. doi:10.3390/antiox9030216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9030216</ArticleId><ArticleId IdType="pmc">PMC7139331</ArticleId><ArticleId IdType="pubmed">32150935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottfried I, Schottlender N, Ashery U. Hyperbaric oxygen treatment-from mechanisms to cognitive improvement. Biomol Ther. 2021;11(10):1520. doi:10.3390/biom11101520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11101520</ArticleId><ArticleId IdType="pmc">PMC8533945</ArticleId><ArticleId IdType="pubmed">34680155</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcinkowska AB, Mankowska ND, Kot J, Winklewski PJ. Impact of hyperbaric oxygen therapy on cognitive functions: a systematic review. Neuropsychol Rev. 2022;32(1):99&#x2013;126. doi:10.1007/s11065-021-09500-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-021-09500-9</ArticleId><ArticleId IdType="pmc">PMC8888529</ArticleId><ArticleId IdType="pubmed">33847854</ArticleId></ArticleIdList></Reference><Reference><Citation>Alashram AR, Padua E, Romagnoli C, Annino G. Hyperbaric oxygen therapy for cognitive impairments in patients with traumatic brain injury: a systematic review. Appl Neuropsychol Adult. 2023;30(5):602&#x2013;13. doi:10.1080/23279095.2022.2041418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23279095.2022.2041418</ArticleId><ArticleId IdType="pubmed">35213282</ArticleId></ArticleIdList></Reference><Reference><Citation>You Q, Li L, Xiong SQ, Yan YF, Li D, Yan NN, et al. Meta-analysis on the efficacy and safety of hyperbaric oxygen as adjunctive therapy for vascular dementia. Front Aging Neurosci. 2019;11:86. doi:10.3389/fnagi.2019.00086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00086</ArticleId><ArticleId IdType="pmc">PMC6478752</ArticleId><ArticleId IdType="pubmed">31057392</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalogna M, Sasson E, Hadanny A, Parag Y, Zilberman-Itskovich S, Efrati S. Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: a randomized, sham-controlled trial. Neuroimage Clin. 2022;36:103218. doi:10.1016/j.nicl.2022.103218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103218</ArticleId><ArticleId IdType="pmc">PMC9528018</ArticleId><ArticleId IdType="pubmed">36208548</ArticleId></ArticleIdList></Reference><Reference><Citation>Loriette C, Ziane C, Ben Hamed S. Neurofeedback for cognitive enhancement and intervention and brain plasticity. Rev Neurol (Paris). 2021;177(9):1133&#x2013;44. doi:10.1016/j.neurol.2021.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2021.08.004</ArticleId><ArticleId IdType="pubmed">34674879</ArticleId></ArticleIdList></Reference><Reference><Citation>Orend&#xe1;&#x10d;ov&#xe1; M, Kva&#x161;&#x148;&#xe1;k E. Possible mechanisms underlying neurological post-COVID symptoms and neurofeedback as a potential therapy. Front Hum Neurosci. 2022;16:837972. doi:10.3389/fnhum.2022.837972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2022.837972</ArticleId><ArticleId IdType="pmc">PMC9010738</ArticleId><ArticleId IdType="pubmed">35431842</ArticleId></ArticleIdList></Reference><Reference><Citation>Boschloo L, Hieronymus F, Cuijpers P. Clinical response to SSRIs relative to cognitive behavioral therapy in depression: a symptom-specific approach. World Psychiatry. 2022;21(1):152&#x2013;3. doi:10.1002/wps.20944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20944</ArticleId><ArticleId IdType="pmc">PMC8751549</ArticleId><ArticleId IdType="pubmed">35015348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucherer S, Ferguson RJ. Cognitive behavioral therapy for cancer-related cognitive dysfunction. Curr Opin Support Palliat Care. 2017;11(1):46&#x2013;51. doi:10.1097/spc.0000000000000247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/spc.0000000000000247</ArticleId><ArticleId IdType="pmc">PMC5285475</ArticleId><ArticleId IdType="pubmed">27898511</ArticleId></ArticleIdList></Reference><Reference><Citation>He HL, Zhang M, Gu CZ, Xue RR, Liu HX, Gao CF, et al. Effect of cognitive behavioral therapy on improving the cognitive function in major and minor depression. J Nerv Ment Dis. 2019;207(4):232&#x2013;8. doi:10.1097/nmd.0000000000000954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nmd.0000000000000954</ArticleId><ArticleId IdType="pubmed">30865075</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuijpers P, Miguel C, Harrer M, Plessen CY, Ciharova M, Ebert D, et al. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry. 2023;22(1):105&#x2013;15. doi:10.1002/wps.21069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.21069</ArticleId><ArticleId IdType="pmc">PMC9840507</ArticleId><ArticleId IdType="pubmed">36640411</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedman-Lagerl&#xf6;f E, Carlbring P, Sv&#xe4;rdman F, Riper H, Cuijpers P, Andersson G. Therapist-supported internet-based cognitive behaviour therapy yields similar effects as face-to-face therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis. World Psychiatry. 2023;22(2):305&#x2013;14. doi:10.1002/wps.21088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.21088</ArticleId><ArticleId IdType="pmc">PMC10168168</ArticleId><ArticleId IdType="pubmed">37159350</ArticleId></ArticleIdList></Reference><Reference><Citation>Far&#xec; G, Lunetti P, Pignatelli G, Raele MV, Cera A, Mintrone G, et al. The effect of physical exercise on cognitive impairment in neurodegenerative disease: from pathophysiology to clinical and rehabilitative aspects. Int J Mol Sci. 2021;22(21). doi:10.3390/ijms222111632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111632</ArticleId><ArticleId IdType="pmc">PMC8583932</ArticleId><ArticleId IdType="pubmed">34769062</ArticleId></ArticleIdList></Reference><Reference><Citation>Torous J, Myrick K, Aguilera A. The need for a new generation of digital mental health tools to support more accessible, effective and equitable care. World Psychiatry. 2023;22(1):1&#x2013;2. doi:10.1002/wps.21058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.21058</ArticleId><ArticleId IdType="pmc">PMC9840484</ArticleId><ArticleId IdType="pubmed">36640397</ArticleId></ArticleIdList></Reference><Reference><Citation>Groenveld T, Achttien R, Smits M, de Vries M, van Heerde R, Staal B, et al. Feasibility of virtual reality exercises at home for post-COVID-19 condition: cohort study. JMIR Rehabil Assist Technol. 2022;9(3):e36836. doi:10.2196/36836.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/36836</ArticleId><ArticleId IdType="pmc">PMC9380776</ArticleId><ArticleId IdType="pubmed">35858254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura J. Computer-based virtual reality assessment of functional capacity in primary psychosis. World Psychiatry. 2022;21(3):464&#x2013;5. doi:10.1002/wps.21024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.21024</ArticleId><ArticleId IdType="pmc">PMC9453893</ArticleId><ArticleId IdType="pubmed">36073705</ArticleId></ArticleIdList></Reference><Reference><Citation>Espie CA, Firth J, Torous J. Evidence-informed is not enough: digital therapeutics also need to be evidence-based. World Psychiatry. 2022;21(2):320&#x2013;1. doi:10.1002/wps.20993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20993</ArticleId><ArticleId IdType="pmc">PMC9077620</ArticleId><ArticleId IdType="pubmed">35524617</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella M, Parri L, Wang K, Quinn R, Oyeleye O, Jin H, et al. Evaluating remote delivery of cognitive remediation in people with psychosis. Schizophr Res. 2024;267:367&#x2013;72. doi:10.1016/j.schres.2024.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2024.04.001</ArticleId><ArticleId IdType="pubmed">38631111</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell I, Pot-Kolder R, Wood SJ, Nelson B, Acevedo N, Stainton A, et al. Digital technology for addressing cognitive impairment in recent-onset psychosis: a perspective. Schizophr Res Cogn. 2022;28:100247. doi:10.1016/j.scog.2022.100247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scog.2022.100247</ArticleId><ArticleId IdType="pmc">PMC8914197</ArticleId><ArticleId IdType="pubmed">35281550</ArticleId></ArticleIdList></Reference><Reference><Citation>Torous J. A path towards progress: lessons from the hard things about digital mental health. World Psychiatry. 2022;21(3):419&#x2013;20. doi:10.1002/wps.21003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.21003</ArticleId><ArticleId IdType="pmc">PMC9453910</ArticleId><ArticleId IdType="pubmed">36073703</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze EJ, Reiersen AM, Santosh PJ. Repurposing fluvoxamine, and other psychiatric medications, for COVID-19 and other conditions. World Psychiatry. 2022;21(2):314&#x2013;5. doi:10.1002/wps.20983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20983</ArticleId><ArticleId IdType="pmc">PMC9077594</ArticleId><ArticleId IdType="pubmed">35524600</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivera E, S&#xe1;ez A, Carniglia L, Caruso C, Lasaga M, Durand D. Alzheimer&#x2019;s disease risk after COVID-19: a view from the perspective of the infectious hypothesis of neurodegeneration. Neural Regen Res. 2023;18(7):1404&#x2013;10. doi:10.4103/1673-5374.360273.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.360273</ArticleId><ArticleId IdType="pmc">PMC10075115</ArticleId><ArticleId IdType="pubmed">36571334</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui T, Mitsuma S, Nagata A, Matsushita S, Asahi T. Accelerated cognitive decline after the COVID-19 pandemic in a community population of older persons with cognitive impairment: a 4-year time series analysis in the Tokyo Metropolis area. Geriatr Gerontol Int. 2023;23(3):200&#x2013;4. doi:10.1111/ggi.14543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.14543</ArticleId><ArticleId IdType="pubmed">36697372</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2; M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75(10):e14357. doi:10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaichana U, Man KKC, Chen A, Wong ICK, George J, Wilson P, et al. Definition of post&#x2013;COVID-19 condition among published research studies. JAMA Netw Open. 2023;6(4):e235856. doi:10.1001/jamanetworkopen.2023.5856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5856</ArticleId><ArticleId IdType="pmc">PMC10077105</ArticleId><ArticleId IdType="pubmed">37017970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan D, Pareek M. Toward a universal definition of post&#x2013;COVID-19 condition&#x2014;how do we proceed? JAMA Netw Open. 2023;6(4):e235779. doi:10.1001/jamanetworkopen.2023.5779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5779</ArticleId><ArticleId IdType="pubmed">37017975</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:o126. doi:10.1136/bmj.o126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o126</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. 2021;4(10):e2130645. doi:10.1001/jamanetworkopen.2021.30645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K, Johnsen S, Sattler S, Nielsen S, Kunalan K, Rungby J, et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. ENP. 2021;46:39&#x2013;48. doi:10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Costas-Carrera A, S&#xe1;nchez-Rodr&#xed;guez MM, Ca&#xf1;izares S, Ojeda A, Mart&#xed;n-Villalba I, Prim&#xe9;-Tous M, et al. Neuropsychological functioning in post-ICU patients after severe COVID-19 infection: the role of cognitive reserve. Brain Behav Immun Health. 2022;21:100425. doi:10.1016/j.bbih.2022.100425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100425</ArticleId><ArticleId IdType="pmc">PMC8818554</ArticleId><ArticleId IdType="pubmed">35156065</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein FC, Hajjar I, Summers A, Truong AD, Lee FFE, Han JE, et al. Frequency and correlates of subjective cognitive complaints and objective cognitive screening results in African American adults following COVID-19 infection. Brain Behav Immun Health. 2023;34:100691. doi:10.1016/j.bbih.2023.100691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100691</ArticleId><ArticleId IdType="pmc">PMC10569942</ArticleId><ArticleId IdType="pubmed">37842136</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmon K, Day GS, Powers HR, Bosch W, Prabhakaran D, Woolston D, et al. Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage. BMC Neurol. 2022;22(1):285. doi:10.1186/s12883-022-02817-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02817-9</ArticleId><ArticleId IdType="pmc">PMC9338515</ArticleId><ArticleId IdType="pubmed">35907815</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang Q, Davis PB, Volkow ND, Xu R. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World Psychiatry. 2022;21(1):124&#x2013;32. doi:10.1002/wps.20921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20921</ArticleId><ArticleId IdType="pmc">PMC8661963</ArticleId><ArticleId IdType="pubmed">34612005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kshirsagar M, Nasir M, Mukherjee S, Becker N, Dodhia R, Weeks WB, et al. The risk of hospitalization and mortality after breakthrough SARS-CoV-2 infection by vaccine type: observational study of medical claims data. JMIR Public Health Surveill. 2022;8(11):e38898. doi:10.2196/38898.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/38898</ArticleId><ArticleId IdType="pmc">PMC9645422</ArticleId><ArticleId IdType="pubmed">36265135</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan L, Sawyer C, Peek N, Lovell K, Carvalho AF, Solmi M, et al. COVID-19 vaccination uptake in people with severe mental illness: a UK-based cohort study. World Psychiatry. 2022;21(1):153&#x2013;4. doi:10.1002/wps.20945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20945</ArticleId><ArticleId IdType="pmc">PMC8751570</ArticleId><ArticleId IdType="pubmed">35015350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzur Bitan D, Givon-Lavi N, Kridin K, Kaliner E, Krieger I, Dov Cohen A, et al. Severe breakthrough COVID-19 infections in vaccinated patients with schizophrenia in Israel. World Psychiatry. 2022;21(3):471&#x2013;2. doi:10.1002/wps.21028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.21028</ArticleId><ArticleId IdType="pmc">PMC9453897</ArticleId><ArticleId IdType="pubmed">36073713</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomonov N, Kanellopoulos D, Grosenick L, Wilkins V, Goldman R, Ritholtz S, et al. CopeNYP: a brief remote psychological intervention reduces health care workers&#x2019; depression and anxiety symptoms during COVID-19 pandemic. World Psychiatry. 2022;21(1):155&#x2013;6. doi:10.1002/wps.20946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20946</ArticleId><ArticleId IdType="pmc">PMC8751568</ArticleId><ArticleId IdType="pubmed">35015344</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>